A prospective Alzheimer’s trial reports

Re:A prospective Alzheimer’s trial reports by vikramkr on Monday February 10, 2020 @04:50PM (#22293776)

And the great thing about safety-and-efficacy regimes is that until you get a drug to work, the market can't be filled. If the FDA makes exceptions for biogen, then the alzheimers market for new drugs shrinks, disincentivizing research into drugs that will actually work. Why invest billions to make drugs that work if you can make that same money by pumping trash into the market?

[ Parent | on HN ]

Re:A prospective Alzheimer’s trial reports by hprotagonist on Monday February 10, 2020 @05:12PM (#22293959)

There's a post for that one, too :) https://blogs.sciencemag.org/pipeline/archives/2018/05/25/fe... and https://blogs.sciencemag.org/pipeline/archives/2018/06/21/we..., which concludes:

the next wave will not be just people who have seized on this plan opportunistically, but who have targeted it right from the start. Who will pick out terrible diseases for which there are no therapies at all, the better to insure a supply of completely desperate patients and families, and provide them with utterly useless therapies at stiff, stiff prices. Utterly harmless therapies, though – don’t want to get sued while you’re raking in the bucks. I’m talking polysaccharide therapy for pancreatic cancer, antioxidant phytonutrients for Alzheimer’s: in other words, corn starch and grape juice. What the hell. The customers are going to die, anyway. Why should they die with their money as well?

[ Parent | on HN ]

Re:A prospective Alzheimer’s trial reports by vikramkr on Monday February 10, 2020 @05:19PM (#22294013)

It's unfortunate that in this legal situation the most it seems regulators can do is avoid giving snake oil regulatory legitimacy and hope that people are dissuaded by "these statements have not been evaluated by the fda, and XYS is not approved to diagnose or treat any disease." At the very least though, it would be nice if the FDA didn't then turn around and give legitimacy to fancier snake oil - hopefully they do the right thing with biogen haha.

[ Parent | on HN ]

Re:A prospective Alzheimer’s trial reports by hprotagonist on Monday February 10, 2020 @05:26PM (#22294086)

You can thank orrin hatch for the total unregulation of the suppliments racket. Or curse him, which is probably the better course of action.

https://blogs.sciencemag.org/pipeline/archives/2019/02/12/th...

for actual drugs, the FDA can and does show up at your plant unannounced with guns for two weeks for an unannounced audit more or less whenever they want.

I await the day they can drop the hammer on the woo-aisle at whole foods with very poorly concealed anticipatory shadenfraude. Right now the best they can do is to sue POM Wonderful and the like : https://www.forbes.com/sites/chloesorvino/2016/05/02/the-ver...

[ Parent | on HN ]

Re:A prospective Alzheimer’s trial reports by vikramkr on Monday February 10, 2020 @05:38PM (#22294188)

I wonder if going after Purell is a way to start testing the extent of their power?

https://www.nytimes.com/2020/01/28/health/purell-fda-ebola-v...

[ Parent | on HN ]